Skip to main content
An official website of the United States government
Email

Executive Roundtable

The application for this program is currently closed.

The NCI Small Business Innovation Research (SBIR) Executive Roundtable program brings together founders and C-level executives of SBIR- and Small Business Technology Transfer (STTR) funded startups for mentorship on an ongoing basis. The Executive Roundtable is only for digital health companies focusing on any of the following technology areas:

  • Educational tools
  • Behavioral medicine
  • Health IT (bioinformatics with or without diagnostic component, artificial intelligence/machine learning)
  • Mobile health
  • Wearable devices for personalized medicine
  • Telehealth/telemedicine

If your technology is not in one of these areas but you still believe you qualify as a digital health company, email us and we can reevaluate.

Benefits

  • Networking and potential partnerships with fellow founders/executives
  • Ongoing mentorship and advice from fellow founders/executives
  • Meeting with NCI SBIR staff to set the foundation for the roundtable
  • Ongoing support from NCI SBIR staff and access to other NIH resources

Details

  • Groups have 10 members each from companies across the United States and meet virtually every two months for about two hours.
  • The NCI team is heavily involved for around six months and then turns leadership over to the group. (NCI will still be involved but to a lesser extent.)
  • After a year, the group is expected to move forward on their own, based on their interest and inclination.

Program Contact

Brittany Connors (brittany.connors@nih.gov)

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Executive Roundtable was originally published by the National Cancer Institute.”

Email